-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MW-032 in Bone Metastasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MW-032 in Bone Metastasis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MW-032 in Bone Metastasis Drug Details: Denosumab biosimilar is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MW-189 in Intracerebral Hemorrhage
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MW-189 in Intracerebral Hemorrhage report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MW-189 in Intracerebral Hemorrhage Drug Details: MW-189 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Intracerebral Hemorrhage
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Intracerebral Hemorrhage report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Intracerebral Hemorrhage Drug Details: Anakinra (Kineret) is an immunosuppressant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Canakinumab in Pyoderma Gangrenosum
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Canakinumab in Pyoderma Gangrenosum report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Canakinumab in Pyoderma Gangrenosum Drug Details: Canakinumab (Ilaris / Lasprona /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LBL-007 in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LBL-007 in Laryngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LBL-007 in Laryngeal Cancer Drug Details: LBL-007 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Canakinumab in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Canakinumab in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Canakinumab in Metastatic Melanoma Drug Details: Canakinumab (Ilaris / Lasprona /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Community Acquired Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Community Acquired Pneumonia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Community Acquired Pneumonia Drug Details: Anakinra (Kineret) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Hospital Acquired Pneumonia (HAP) Drug Details: Anakinra...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Canakinumab in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Canakinumab in Myelodysplastic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Canakinumab in Myelodysplastic Syndrome Drug Details: Canakinumab (Ilaris / Lasprona /...